Edit
AIMM Therapeutics
http://www.aimmtherapeutics.com/Last activity: -
Active - Reference to Kling Biotherapeutics BV
AIMM is a biotech company spun-out of the Netherlands Cancer Institute and the Academic Medical Center at the University of Amsterdam. The company aims to develop high quality human monoclonal antibodies to treat diseases with a high, unmet medical need. AIMM exploits and develops new, innovative technologies to generate stable monoclonal cell lines of human antibody-producing B cells against infectious agents.